Oral AbstractsOA 17.02 Updated Efficacy Results From the BIRCH Study: First-Line Atezolizumab Therapy in PD-L1–Selected Patients With Advanced NSCLC
Under an Elsevier user license
open archive
Cited by (0)
Copyright © 2017 Published by Elsevier Inc.